228 related articles for article (PubMed ID: 34511023)
1. Sevoflurane promotes the apoptosis of laryngeal squamous cell carcinoma in-vitro and inhibits its malignant progression via miR-26a/FOXO1 axis.
Liu D; Wan L; Gong H; Chen S; Kong Y; Xiao B
Bioengineered; 2021 Dec; 12(1):6364-6376. PubMed ID: 34511023
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-26a inhibits proliferation and tumorigenesis via targeting CKS2 in laryngeal squamous cell carcinoma.
Wu Z; Lu B; Li X; Miao W; Li J; Shi Y; Yu W
Clin Exp Pharmacol Physiol; 2018 May; 45(5):444-451. PubMed ID: 29143362
[TBL] [Abstract][Full Text] [Related]
3. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
Zheng Y; Duan L; Yang Y; Luo D; Yan B
Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
[TBL] [Abstract][Full Text] [Related]
5. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
[TBL] [Abstract][Full Text] [Related]
6. Long intergenic non-protein coding RNA 847 promotes laryngeal squamous cell carcinoma progression through the microRNA-181a-5p/zinc finger E-box binding homeobox 2 axis.
Li W; Hu X; Huang X
Bioengineered; 2022 Apr; 13(4):9987-10000. PubMed ID: 35435130
[TBL] [Abstract][Full Text] [Related]
7. MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9.
Lv Y; Ye D; Qiu S; Zhang J; Shen Z; Shen Y; Deng H
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31519771
[TBL] [Abstract][Full Text] [Related]
8. MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells.
Luo HN; Wang ZH; Sheng Y; Zhang Q; Yan J; Hou J; Zhu K; Cheng Y; Xu YL; Zhang XH; Xu M; Ren XY
Med Oncol; 2014 Jan; 31(1):789. PubMed ID: 24318902
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/CXCR4 axis.
Zhao J; Li XD; Wang M; Song LN; Zhao MJ
Aging (Albany NY); 2021 May; 13(10):14078-14087. PubMed ID: 34015764
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
Wang Z; Huang C; Zhang A; Lu C; Liu L
Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
[TBL] [Abstract][Full Text] [Related]
11. TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2.
He G; Pang R; Han J; Jia J; Ding Z; Bi W; Yu J; Chen L; Zhang J; Sun Y
BMC Cancer; 2021 Jun; 21(1):753. PubMed ID: 34187411
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.
Tian L; Zhang J; Ge J; Xiao H; Lu J; Fu S; Liu M; Sun Y
Med Oncol; 2014 Jan; 31(1):785. PubMed ID: 24297308
[TBL] [Abstract][Full Text] [Related]
13. [The effect of miR-497 on laryngeal squamous cell carcinoma invasion through modulating PlexinA4].
Niu JT; Liu SG; Huang YW; Li C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):124-130. PubMed ID: 29429182
[No Abstract] [Full Text] [Related]
14. MiR-196b affects the progression and prognosis of human LSCC through targeting PCDH-17.
Luo M; Sun G; Sun JW
Auris Nasus Larynx; 2019 Aug; 46(4):583-592. PubMed ID: 30454973
[TBL] [Abstract][Full Text] [Related]
15. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
Liu C; Lu Z; Liu H; Zhuang S; Guo P
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
[TBL] [Abstract][Full Text] [Related]
16. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
[TBL] [Abstract][Full Text] [Related]
17. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.
Zhao X; Zhang W; Ji W
Future Oncol; 2018 Jul; 14(17):1741-1753. PubMed ID: 29517349
[TBL] [Abstract][Full Text] [Related]
18. Hsa_circ_0042823 accelerates cancer progression
Wu T; Sun Y; Sun Z; Li S; Wang W; Yu B; Wang G
Ann Med; 2021 Dec; 53(1):960-970. PubMed ID: 34124974
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.
Li Y; Tao C; Dai L; Cui C; Chen C; Wu H; Wei Q; Zhou X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30563928
[TBL] [Abstract][Full Text] [Related]
20. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
